Table 1 Demographic and clinical features of the EEG dataset.

From: Neocortical localization and thalamocortical modulation of neuronal hyperexcitability contribute to Fragile X Syndrome

Measure

FXS (n = 70)

Controls (n = 71)

t

p

adj. p.

Age (Years)

20.5 ± 10.0

22.2 ± 10.7

<0.001

0.35

0.70

Sex

F: 32 M: 38

F: 30 M: 41

0.17

0.72

0.72

FSIQ

49.5 ± 30.2

103.2 ± 9.2

<0.001

<0.001

<0.001

NVIQ

40 ± 35.7

103.4 ± 10.7

−12.56

<0.001

<0.001

VIQ

58.9 ± 28.7

103.1 ± 12.8

−10.45

<0.001

<0.001

SCQ

13.6 ± 7.7

2.1 ± 2.2

9.94

<0.001

<0.001

WJ-III

67.8 ± 15.7

94.1 ± 12.1

<0.001

<0.001

<0.001

ADAMS-Anxiety

7.2 ± 5.0

2.1 ± 2.6

6.37

<0.001

<0.001

ADAMS-OCD

2.3 ± 2.5

0.4 ± 1.1

5.12

<0.001

<0.001

  1. Showing mean (±standard deviation) group t-tests by group.
  2. FXS Fragile X Syndrome, F female, M male, FSIQ Full Scale IQ, NVIQ Non-verbal intelligence scale, VIQ verbal intelligence scale, SCQ Social Communication Questionnaire, WJ-3 Woodcock III Tests of Cognitive Abilities, ADAMS Anxiety, Depression, and Mood Scale, t t-statistic following independent Student t tests, p unadjusted significance, adj. p p value following Bonferroni correction.
Back to article page